LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. Molin ...

Core Insights - Humana Inc. is a significant player in the health insurance sector, particularly known for its Medicare offerings, competing with major insurers like UnitedHealth Group and Anthem [1] - Barclays analyst Andrew Mok has set a price target of $234 for Humana, indicating a potential upside of approximately 2.09% from its current trading price of $229.20 [2][6] - Berman Tabacco, a national law firm, is investigating Humana for potential illegal kickbacks to insurance brokers, with allegations involving up to $250 million paid to influence broker decisions [3][4][6] Financial Performance - Humana's stock is currently priced at $229.20, reflecting an increase of approximately 0.92% or $2.10, with a market capitalization of around $27.57 billion [5][6] - The stock has experienced fluctuations, with a low of $222.04 and a high of $229.82 during the trading day, and over the past year, it reached a high of $315.35 and a low of $206.87 [5]

Humana filed to appeal a ruling upholding cuts to its Medicare quality bonus payments, the next chapter in the company’s long-running attempt to restore the lost revenue https://t.co/MZyRaH6x6d ...

BREAKING: Core PPI Tame, Retail Sales Light Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! IBD Videos Get market updates, educational videos, webinars, and stock analysis. 'Money Sucking' S&P 500 Stocks Dive On Government Funding Deal 11/10/2025The deal leaves the fate of expiring ACA subsidies unclear. 11/10/2025The deal leaves the fate of expiring ACA subsidies unclear. INVESTING RESOURCES Take a Trial Today President Trump ...

CANADA - 2025/09/05: In this photo illustration, the Oscar Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesOscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via the Affordable Care Act (ACA) Marketplace. This surge signifies investor confide ...

Core Viewpoint - UnitedHealth Group Inc (NYSE:UNH) is identified as a top non-AI stock favored by Reddit investors, despite a 35% decline in stock price this year, with expectations for long-term recovery and growth [2]. Group 1: Financial Performance - UnitedHealth reported better-than-expected quarterly results and raised its full-year earnings outlook [2]. - The company anticipates margin improvements starting in 2026, aiming for the upper half of the 2% to 4% range by 2027 [3]. - Analysts suggest that the medical cost ratio is showing signs of peaking, which could positively impact margins [3]. Group 2: Business Model and Competitive Advantage - UnitedHealth is the largest and most diversified health insurer in the U.S., with two main platforms: UnitedHealthcare and Optum, providing a comprehensive range of services [4]. - The integrated model of UnitedHealth offers unmatched scale and insights into healthcare costs, leading to efficiency and improved outcomes [4]. - The company benefits from strong demographics, particularly the aging U.S. population, which drives steady Medicare Advantage enrollment [4]. Group 3: Investment Perspective - Despite near-term elevated medical costs affecting margins, these challenges are viewed as temporary, with expectations for a return to historical margin levels [4]. - UnitedHealth's recurring revenue base, diversified earnings, and financial strength provide attractive downside protection for investors [4]. - The current valuation presents a compelling opportunity to invest in a structural growth leader with resilient cash flows [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 2, 2025 [3]. - The lawsuit alleges that Molina failed to disclose critical information regarding its medical cost trend assumptions and the impact on its financial guidance for fiscal year 2025 [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Specifics - The lawsuit claims that Molina's near-term growth was reliant on a lack of utilization of various health services, which was not disclosed to investors [5]. - The misleading positive statements made by Molina regarding its business operations and prospects are central to the claims in the lawsuit [5].

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important December 2, 2025 lead plaintiff deadline. SO WHAT: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Molina Healthcare, Inc. (NYSE: MOH). Shareholders who purchased shares of MOH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/molina-healthcare-inc-loss-submission-form/?id=178587&from=3  CLASS PERIOD: Fe ...

Core Insights - President Trump is expected to announce a plan to extend Affordable Care Act (ACA) subsidies, which has led to a surge in shares of major health insurers [1][5] - The proposed plan may extend ACA subsidies for approximately two years and could introduce new income limits for enrollees, along with minimum premium payments [1][2] Group 1: Market Reaction - Shares of Molina Healthcare (MOH) increased by over 3%, Centene (CNC) rose by 5%, and Oscar Health (OSCR) saw an 18% jump following the news [1] - The potential extension of subsidies is anticipated to stabilize enrollment and reduce volatility in the individual health insurance market [2] Group 2: Legislative Context - The ACA subsidies were a contentious issue during the recent government shutdown, with Democratic lawmakers blocking funding bills to extend these subsidies [3] - The White House plans to request Congress to approve funds aimed at reducing cost-sharing, which would lower out-of-pocket expenses for some ACA recipients [2]